Genitourinary Drugs Market by Trend, Size, Share & 2023 Growth Forecast Research and Analysis Report & Top Vendor Astellas, Pfizer, GlaxoSmithKline, Eli Lilly, Bayer AG
Genitourinary Drugs has causes for these disorders include congenital anomalies, infectious diseases. Estimated to die of prostate cancer, according to the National Institute of Health (NIH), the number of new cases of ovarian cancer was 11 per 100,000 women, per year, and the number of deaths was 7 per 100,000 women, per year. Hence, Genitourinary Drugs Market has lead to grow due to rise in disease.
View full press release